GlassScriptPhysician profile
Gerald Lee Wasko
NPI 1265874267
$808.47
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $788 · 2022: $20.81.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.31 | 2019 | |
| Glaxosmithkline, LLC. | $127.27 | 2019 | |
| Novo Nordisk INC | $126.38 | 2019 | |
| Pfizer INC. | $71.70 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $64.82 | 2019 | |
| Merck Sharp & Dohme LLC | $49.48 | 2019 | |
| Janssen Pharmaceuticals, INC | $49.14 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.35 | 2019 | |
| Amarin Pharma, INC. | $26.94 | 2019 | |
| Lilly USA, LLC | $23.34 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $21.36 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $20.81 | 2022 | |
| Amgen INC. | $19.80 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.83 | 2019 | |
| Allergan, INC. | $10.94 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Wasko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.